Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
 
 
nutrients-logo

Journal Browser

Journal Browser

Prevention and Treatment of Liver Diseases by Dietary Habits and Lifestyle

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutritional Epidemiology".

Deadline for manuscript submissions: 15 December 2024 | Viewed by 1181

Special Issue Editors


E-Mail Website
Guest Editor
Clinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy
Interests: nutrients; nuclear receptors; gut–liver axis; tumorigenesis; cholesterol and lipid metabolism
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Clinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy
Interests: nutrition; nutrigenomics; pathophysiology of the gut–liver axis; gastrointestinal; Mediterranean diet

Special Issue Information

Dear Colleagues,

Liver diseases are often associated with metabolic conditions, such as metabolic dysfunction-associated steatotic liver disease (MASLD). The definition of MASLD has been rebranded, shifting the definition of non-alcoholic fatty liver disease (NAFLD), and is now more representative of the clinical and metabolic heterogeneity characterizing patients presenting with the accumulation of excess fat in the liver in the presence of other cardiometabolic risk factors. Dietary habits and lifestyle have a critical impact on the pathogenesis of liver diseases. Evidence shows that a balanced diet together with moderate and regular exercise as adjuvant therapeutic strategies in these patients are successfully improving steatosis, inflammation, hepatocyte ballooning, and fibrosis, which can even lead to the development of hepatocellular carcinoma. The clinical and metabolic benefits of lifestyle management are mainly achieved via mechanisms encompassing nutrigenomics, gut microbiota modulation, improvement in mitochondrial dysfunctions and oxidative stress, and the inhibition of inflammatory pathways.

In this Special Issue, we aim to summarize the main evidence on dietary habits and lifestyle in the prevention and treatment of liver diseases, and we welcome reviews, perspectives, short communications, and original research to reinforce the critical importance of lifestyle intervention and comprehensive management in addressing this growing global health concern.

Dr. Marica Cariello
Dr. Raffaella Maria Gadaleta
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • liver diseases
  • MASLD
  • lifestyle
  • dietary habits
  • nutrition

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 2210 KiB  
Article
Reassessing the Impact of Coffee Consumption on Liver Disease: Insights from a Large-Scale Cohort Study with IPTW Adjustment
by Keungmo Yang, Young Chang, Soung Won Jeong, Jae Young Jang and Tom Ryu
Nutrients 2024, 16(13), 2020; https://doi.org/10.3390/nu16132020 - 26 Jun 2024
Viewed by 1046
Abstract
Coffee consumption is globally widespread and has become a lifestyle habit. This study investigated coffee consumption and liver-related survival in a large cohort of 455,870 individuals with UK biobank, categorized into without steatosis, metabolic dysfunction-associated steatotic liver disease (MASLD), and MASLD and increased [...] Read more.
Coffee consumption is globally widespread and has become a lifestyle habit. This study investigated coffee consumption and liver-related survival in a large cohort of 455,870 individuals with UK biobank, categorized into without steatosis, metabolic dysfunction-associated steatotic liver disease (MASLD), and MASLD and increased alcohol intake (MetALD). Inverse probability of treatment weighting (IPTW) adjusted for confounding variables was used, followed by Kaplan–Meier analysis. Moderate coffee consumption (1–2 cups per day) was associated with lower all-cause mortality across the entire cohort, without the steatosis, MASLD (p < 0.0001), and MetALD cohorts (p = 0.0047 for pre-IPTW, p = 0.027 for post-IPTW). Before IPTW adjustment, consuming one or more cups of coffee per day appeared to significantly reduce liver-related mortality in the overall (p = 0.015) and MASLD cohorts (p = 0.011). However, post-IPTW application, no significant differences in liver-related mortality were observed between the coffee intake groups (p = 0.778, 0.319, 0.564, 0.238 for each group). While increased coffee consumption initially seemed to reduce liver-related mortality, after IPTW adjustment, only all-cause mortality significantly decreased (p < 0.0001 and p = 0.027). These findings suggest that previous studies might have overestimated the favorable effect of coffee intake on chronic liver disease due to confounding factors. Full article
Show Figures

Graphical abstract

Back to TopTop